Bayer AG annual revenue
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Bayer AG Revenue Growth & History (BAYN)
Bayer AG reported €45.58B in revenue for fiscal 2025, a decrease of 2.21% from the previous fiscal year.
View full Bayer AG company overviewBayer AG annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €45.58B | −€1.03B | −2.21% |
| 2024 | 2024-12-31 | €46.61B | −€1.03B | −2.16% |
| 2023 | 2023-12-31 | €47.64B | −€3.10B | −6.11% |
| 2022 | 2022-12-31 | €50.74B | €6.66B | +15.10% |
| 2021 | 2021-12-31 | €44.08B | €2.68B | +6.48% |
| 2020 | 2020-12-31 | €41.40B | −€2.15B | −4.93% |
| 2019 | 2019-12-31 | €43.55B | €3.96B | +10.00% |
| 2018 | 2018-12-31 | €39.59B | €4.57B | +13.05% |
| 2017 | 2017-12-31 | €35.02B | −€11.75B | −25.13% |
| 2016 | 2016-12-31 | €46.77B | €445.0M | +0.96% |
| 2015 | 2015-12-31 | €46.32B | €4.08B | +9.67% |
| 2014 | 2014-12-31 | €42.24B | €2.08B | +5.18% |
| 2013 | 2013-12-31 | €40.16B | €397.0M | +1.00% |
| 2012 | 2012-12-31 | €39.76B | €3.23B | +8.85% |
| 2011 | 2011-12-31 | €36.53B | €1.44B | +4.10% |
| 2010 | 2010-12-31 | €35.09B | — | — |
Bayer AG quarterly revenue
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | €10.87B | €133.0M | +1.24% |
| Q1 2026 | 2026-03-31 | €13.40B | — | — |
| Q4 2025 | 2025-12-31 | €11.44B | — | — |
| Q3 2025 | 2025-09-30 | €9.66B | — | — |
| Q2 2025 | 2025-06-30 | €10.74B | — | — |
Bayer AG revenue growth trends
Over the last five reported fiscal years, revenue grew from €41.40B to €45.58B, a compound annual growth rate of 1.94%. Bayer AG's latest reported quarter, Q2 2026, generated €10.87B in revenue, an increase of 1.24% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Bayer AG source filings ↗Community posts
Bayer wins the first Roundup trial following the Supreme Court ruling
A Missouri jury unanimously ruled for Bayer ($BAYN)’s Monsanto unit in a three-plaintiff Roundup case, rejecting design-defect, fraud and negligence claims. It was the first such trial following the US Supreme Court decision that blocked th ...
Bayer’s Nubeqa cuts risk of metastasis or death in prostate trial
Bayer ($BAYN) disclosed interim Phase 3 results showing that adding Nubeqa to hormone therapy and radiation reduced the risk of metastasis or death by 58% in prostate-cancer patients at high risk of recurrence. Four-year metastasis-free sur ...
